Global Antenatal Screening Supply, Demand and Key Producers, 2026-2032
The global Antenatal Screening market size is expected to reach $ 7887 million by 2032, rising at a market growth of 6.7% CAGR during the forecast period (2026-2032).
Antenatal Screening refers to the set of clinical tests and assessments offered during pregnancy to evaluate the risk of genetic, chromosomal, or congenital conditions in the developing fetus. It is intended to identify potential health concerns early, support informed medical and personal decision making, and guide further diagnostic testing or pregnancy management when elevated risk is detected.
The antenatal screening market is shaped by its position at the intersection of routine prenatal care, evolving clinical guidelines, and increasing parental demand for early risk awareness. The market benefits from broad integration into obstetric workflows and relatively flexible adoption compared with postnatal public health programs, allowing faster uptake of new screening approaches and service models. Competitive differentiation is driven by test accuracy, turnaround time, counseling support, and seamless integration with clinical decision making rather than by scale alone. As expectations around informed pregnancy management rise, the market continues to shift toward more comprehensive screening portfolios and service quality improvements while remaining sensitive to ethical considerations and reimbursement policies.
This report studies the global Antenatal Screening demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antenatal Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antenatal Screening that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antenatal Screening total market, 2021-2032, (USD Million)
Global Antenatal Screening total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Antenatal Screening total market, key domestic companies, and share, (USD Million)
Global Antenatal Screening revenue by player, revenue and market share 2021-2026, (USD Million)
Global Antenatal Screening total market by Type, CAGR, 2021-2032, (USD Million)
Global Antenatal Screening total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Antenatal Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Veritas Genetics, GGA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Antenatal Screening market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Antenatal Screening Market, By Region:
1. How big is the global Antenatal Screening market?
2. What is the demand of the global Antenatal Screening market?
3. What is the year over year growth of the global Antenatal Screening market?
4. What is the total value of the global Antenatal Screening market?
5. Who are the Major Players in the global Antenatal Screening market?
6. What are the growth factors driving the market demand?
Antenatal Screening refers to the set of clinical tests and assessments offered during pregnancy to evaluate the risk of genetic, chromosomal, or congenital conditions in the developing fetus. It is intended to identify potential health concerns early, support informed medical and personal decision making, and guide further diagnostic testing or pregnancy management when elevated risk is detected.
The antenatal screening market is shaped by its position at the intersection of routine prenatal care, evolving clinical guidelines, and increasing parental demand for early risk awareness. The market benefits from broad integration into obstetric workflows and relatively flexible adoption compared with postnatal public health programs, allowing faster uptake of new screening approaches and service models. Competitive differentiation is driven by test accuracy, turnaround time, counseling support, and seamless integration with clinical decision making rather than by scale alone. As expectations around informed pregnancy management rise, the market continues to shift toward more comprehensive screening portfolios and service quality improvements while remaining sensitive to ethical considerations and reimbursement policies.
This report studies the global Antenatal Screening demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antenatal Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antenatal Screening that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antenatal Screening total market, 2021-2032, (USD Million)
Global Antenatal Screening total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Antenatal Screening total market, key domestic companies, and share, (USD Million)
Global Antenatal Screening revenue by player, revenue and market share 2021-2026, (USD Million)
Global Antenatal Screening total market by Type, CAGR, 2021-2032, (USD Million)
Global Antenatal Screening total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Antenatal Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Veritas Genetics, GGA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Antenatal Screening market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Antenatal Screening Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Serum Biomarker Screening
- Ultrasonographic Imaging Screening
- Others
- First-trimester Screening
- Second-trimester Screening
- Late-pregnancy Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- Rainbow Genomics
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
1. How big is the global Antenatal Screening market?
2. What is the demand of the global Antenatal Screening market?
3. What is the year over year growth of the global Antenatal Screening market?
4. What is the total value of the global Antenatal Screening market?
5. Who are the Major Players in the global Antenatal Screening market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Antenatal Screening Introduction
1.2 World Antenatal Screening Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Antenatal Screening Total Market by Region (by Headquarter Location)
1.3.1 World Antenatal Screening Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Antenatal Screening Revenue (2021-2032)
1.3.3 China Based Company Antenatal Screening Revenue (2021-2032)
1.3.4 Europe Based Company Antenatal Screening Revenue (2021-2032)
1.3.5 Japan Based Company Antenatal Screening Revenue (2021-2032)
1.3.6 South Korea Based Company Antenatal Screening Revenue (2021-2032)
1.3.7 ASEAN Based Company Antenatal Screening Revenue (2021-2032)
1.3.8 India Based Company Antenatal Screening Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antenatal Screening Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Antenatal Screening Consumption Value (2021-2032)
2.2 World Antenatal Screening Consumption Value by Region
2.2.1 World Antenatal Screening Consumption Value by Region (2021-2026)
2.2.2 World Antenatal Screening Consumption Value Forecast by Region (2027-2032)
2.3 United States Antenatal Screening Consumption Value (2021-2032)
2.4 China Antenatal Screening Consumption Value (2021-2032)
2.5 Europe Antenatal Screening Consumption Value (2021-2032)
2.6 Japan Antenatal Screening Consumption Value (2021-2032)
2.7 South Korea Antenatal Screening Consumption Value (2021-2032)
2.8 ASEAN Antenatal Screening Consumption Value (2021-2032)
2.9 India Antenatal Screening Consumption Value (2021-2032)
3 WORLD ANTENATAL SCREENING COMPANIES COMPETITIVE ANALYSIS
3.1 World Antenatal Screening Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antenatal Screening Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antenatal Screening in 2025
3.2.3 Global Concentration Ratios (CR8) for Antenatal Screening in 2025
3.3 Antenatal Screening Company Evaluation Quadrant
3.4 Antenatal Screening Market: Overall Company Footprint Analysis
3.4.1 Antenatal Screening Market: Region Footprint
3.4.2 Antenatal Screening Market: Company Product Type Footprint
3.4.3 Antenatal Screening Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antenatal Screening Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antenatal Screening Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Antenatal Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Antenatal Screening Consumption Value Comparison
4.2.1 United States VS China: Antenatal Screening Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Antenatal Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Antenatal Screening Companies and Market Share, 2021-2026
4.3.1 United States Based Antenatal Screening Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antenatal Screening Revenue, (2021-2026)
4.4 China Based Companies Antenatal Screening Revenue and Market Share, 2021-2026
4.4.1 China Based Antenatal Screening Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antenatal Screening Revenue, (2021-2026)
4.5 Rest of World Based Antenatal Screening Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Antenatal Screening Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Antenatal Screening Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Antenatal Screening Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Serum Biomarker Screening
5.2.2 Ultrasonographic Imaging Screening
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Antenatal Screening Market Size by Type (2021-2026)
5.3.2 World Antenatal Screening Market Size by Type (2027-2032)
5.3.3 World Antenatal Screening Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SCREENING TIMING
6.1 World Antenatal Screening Market Size Overview by Screening Timing: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Timing
6.2.1 First-trimester Screening
6.2.2 Second-trimester Screening
6.2.3 Late-pregnancy Screening
6.3 Market Segment by Screening Timing
6.3.1 World Antenatal Screening Market Size by Screening Timing (2021-2026)
6.3.2 World Antenatal Screening Market Size by Screening Timing (2027-2032)
6.3.3 World Antenatal Screening Market Size Market Share by Screening Timing (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Antenatal Screening Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Antenatal Screening Market Size by Service Model (2021-2026)
7.3.2 World Antenatal Screening Market Size by Service Model (2027-2032)
7.3.3 World Antenatal Screening Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Antenatal Screening Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Antenatal Screening Market Size by Application (2021-2026)
8.3.2 World Antenatal Screening Market Size by Application (2027-2032)
8.3.3 World Antenatal Screening Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Antenatal Screening Product and Services
9.1.4 Thermo Fisher Scientific Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Revvity
9.2.1 Revvity Details
9.2.2 Revvity Major Business
9.2.3 Revvity Antenatal Screening Product and Services
9.2.4 Revvity Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Revvity Recent Developments/Updates
9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Antenatal Screening Product and Services
9.3.4 Quest Diagnostics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Antenatal Screening Product and Services
9.4.4 MedGenome Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Antenatal Screening Product and Services
9.5.4 Mayo Clinic Laboratories Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 GeneDx
9.6.1 GeneDx Details
9.6.2 GeneDx Major Business
9.6.3 GeneDx Antenatal Screening Product and Services
9.6.4 GeneDx Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GeneDx Recent Developments/Updates
9.6.6 GeneDx Competitive Strengths & Weaknesses
9.7 PreventionGenetics
9.7.1 PreventionGenetics Details
9.7.2 PreventionGenetics Major Business
9.7.3 PreventionGenetics Antenatal Screening Product and Services
9.7.4 PreventionGenetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 PreventionGenetics Recent Developments/Updates
9.7.6 PreventionGenetics Competitive Strengths & Weaknesses
9.8 SYNLAB
9.8.1 SYNLAB Details
9.8.2 SYNLAB Major Business
9.8.3 SYNLAB Antenatal Screening Product and Services
9.8.4 SYNLAB Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 SYNLAB Recent Developments/Updates
9.8.6 SYNLAB Competitive Strengths & Weaknesses
9.9 Veritas Genetics
9.9.1 Veritas Genetics Details
9.9.2 Veritas Genetics Major Business
9.9.3 Veritas Genetics Antenatal Screening Product and Services
9.9.4 Veritas Genetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Veritas Genetics Recent Developments/Updates
9.9.6 Veritas Genetics Competitive Strengths & Weaknesses
9.10 GGA
9.10.1 GGA Details
9.10.2 GGA Major Business
9.10.3 GGA Antenatal Screening Product and Services
9.10.4 GGA Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 GGA Recent Developments/Updates
9.10.6 GGA Competitive Strengths & Weaknesses
9.11 Cordlife
9.11.1 Cordlife Details
9.11.2 Cordlife Major Business
9.11.3 Cordlife Antenatal Screening Product and Services
9.11.4 Cordlife Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cordlife Recent Developments/Updates
9.11.6 Cordlife Competitive Strengths & Weaknesses
9.12 Rainbow Genomics
9.12.1 Rainbow Genomics Details
9.12.2 Rainbow Genomics Major Business
9.12.3 Rainbow Genomics Antenatal Screening Product and Services
9.12.4 Rainbow Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Rainbow Genomics Recent Developments/Updates
9.12.6 Rainbow Genomics Competitive Strengths & Weaknesses
9.13 BGI Genomics
9.13.1 BGI Genomics Details
9.13.2 BGI Genomics Major Business
9.13.3 BGI Genomics Antenatal Screening Product and Services
9.13.4 BGI Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BGI Genomics Recent Developments/Updates
9.13.6 BGI Genomics Competitive Strengths & Weaknesses
9.14 Berry Genomics
9.14.1 Berry Genomics Details
9.14.2 Berry Genomics Major Business
9.14.3 Berry Genomics Antenatal Screening Product and Services
9.14.4 Berry Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Berry Genomics Recent Developments/Updates
9.14.6 Berry Genomics Competitive Strengths & Weaknesses
9.15 Annaroad
9.15.1 Annaroad Details
9.15.2 Annaroad Major Business
9.15.3 Annaroad Antenatal Screening Product and Services
9.15.4 Annaroad Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Annaroad Recent Developments/Updates
9.15.6 Annaroad Competitive Strengths & Weaknesses
9.16 Jiajian Medical Testing
9.16.1 Jiajian Medical Testing Details
9.16.2 Jiajian Medical Testing Major Business
9.16.3 Jiajian Medical Testing Antenatal Screening Product and Services
9.16.4 Jiajian Medical Testing Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Jiajian Medical Testing Recent Developments/Updates
9.16.6 Jiajian Medical Testing Competitive Strengths & Weaknesses
9.17 Genesky
9.17.1 Genesky Details
9.17.2 Genesky Major Business
9.17.3 Genesky Antenatal Screening Product and Services
9.17.4 Genesky Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Genesky Recent Developments/Updates
9.17.6 Genesky Competitive Strengths & Weaknesses
9.18 Weihansi Biomedical Technology
9.18.1 Weihansi Biomedical Technology Details
9.18.2 Weihansi Biomedical Technology Major Business
9.18.3 Weihansi Biomedical Technology Antenatal Screening Product and Services
9.18.4 Weihansi Biomedical Technology Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Weihansi Biomedical Technology Recent Developments/Updates
9.18.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Antenatal Screening Industry Chain
10.2 Antenatal Screening Upstream Analysis
10.3 Antenatal Screening Midstream Analysis
10.4 Antenatal Screening Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Antenatal Screening Introduction
1.2 World Antenatal Screening Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Antenatal Screening Total Market by Region (by Headquarter Location)
1.3.1 World Antenatal Screening Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Antenatal Screening Revenue (2021-2032)
1.3.3 China Based Company Antenatal Screening Revenue (2021-2032)
1.3.4 Europe Based Company Antenatal Screening Revenue (2021-2032)
1.3.5 Japan Based Company Antenatal Screening Revenue (2021-2032)
1.3.6 South Korea Based Company Antenatal Screening Revenue (2021-2032)
1.3.7 ASEAN Based Company Antenatal Screening Revenue (2021-2032)
1.3.8 India Based Company Antenatal Screening Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antenatal Screening Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Antenatal Screening Consumption Value (2021-2032)
2.2 World Antenatal Screening Consumption Value by Region
2.2.1 World Antenatal Screening Consumption Value by Region (2021-2026)
2.2.2 World Antenatal Screening Consumption Value Forecast by Region (2027-2032)
2.3 United States Antenatal Screening Consumption Value (2021-2032)
2.4 China Antenatal Screening Consumption Value (2021-2032)
2.5 Europe Antenatal Screening Consumption Value (2021-2032)
2.6 Japan Antenatal Screening Consumption Value (2021-2032)
2.7 South Korea Antenatal Screening Consumption Value (2021-2032)
2.8 ASEAN Antenatal Screening Consumption Value (2021-2032)
2.9 India Antenatal Screening Consumption Value (2021-2032)
3 WORLD ANTENATAL SCREENING COMPANIES COMPETITIVE ANALYSIS
3.1 World Antenatal Screening Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antenatal Screening Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antenatal Screening in 2025
3.2.3 Global Concentration Ratios (CR8) for Antenatal Screening in 2025
3.3 Antenatal Screening Company Evaluation Quadrant
3.4 Antenatal Screening Market: Overall Company Footprint Analysis
3.4.1 Antenatal Screening Market: Region Footprint
3.4.2 Antenatal Screening Market: Company Product Type Footprint
3.4.3 Antenatal Screening Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antenatal Screening Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antenatal Screening Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Antenatal Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Antenatal Screening Consumption Value Comparison
4.2.1 United States VS China: Antenatal Screening Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Antenatal Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Antenatal Screening Companies and Market Share, 2021-2026
4.3.1 United States Based Antenatal Screening Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antenatal Screening Revenue, (2021-2026)
4.4 China Based Companies Antenatal Screening Revenue and Market Share, 2021-2026
4.4.1 China Based Antenatal Screening Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antenatal Screening Revenue, (2021-2026)
4.5 Rest of World Based Antenatal Screening Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Antenatal Screening Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Antenatal Screening Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Antenatal Screening Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Serum Biomarker Screening
5.2.2 Ultrasonographic Imaging Screening
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Antenatal Screening Market Size by Type (2021-2026)
5.3.2 World Antenatal Screening Market Size by Type (2027-2032)
5.3.3 World Antenatal Screening Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SCREENING TIMING
6.1 World Antenatal Screening Market Size Overview by Screening Timing: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Timing
6.2.1 First-trimester Screening
6.2.2 Second-trimester Screening
6.2.3 Late-pregnancy Screening
6.3 Market Segment by Screening Timing
6.3.1 World Antenatal Screening Market Size by Screening Timing (2021-2026)
6.3.2 World Antenatal Screening Market Size by Screening Timing (2027-2032)
6.3.3 World Antenatal Screening Market Size Market Share by Screening Timing (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Antenatal Screening Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Antenatal Screening Market Size by Service Model (2021-2026)
7.3.2 World Antenatal Screening Market Size by Service Model (2027-2032)
7.3.3 World Antenatal Screening Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Antenatal Screening Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Antenatal Screening Market Size by Application (2021-2026)
8.3.2 World Antenatal Screening Market Size by Application (2027-2032)
8.3.3 World Antenatal Screening Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Antenatal Screening Product and Services
9.1.4 Thermo Fisher Scientific Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Revvity
9.2.1 Revvity Details
9.2.2 Revvity Major Business
9.2.3 Revvity Antenatal Screening Product and Services
9.2.4 Revvity Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Revvity Recent Developments/Updates
9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Antenatal Screening Product and Services
9.3.4 Quest Diagnostics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Antenatal Screening Product and Services
9.4.4 MedGenome Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Antenatal Screening Product and Services
9.5.4 Mayo Clinic Laboratories Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 GeneDx
9.6.1 GeneDx Details
9.6.2 GeneDx Major Business
9.6.3 GeneDx Antenatal Screening Product and Services
9.6.4 GeneDx Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GeneDx Recent Developments/Updates
9.6.6 GeneDx Competitive Strengths & Weaknesses
9.7 PreventionGenetics
9.7.1 PreventionGenetics Details
9.7.2 PreventionGenetics Major Business
9.7.3 PreventionGenetics Antenatal Screening Product and Services
9.7.4 PreventionGenetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 PreventionGenetics Recent Developments/Updates
9.7.6 PreventionGenetics Competitive Strengths & Weaknesses
9.8 SYNLAB
9.8.1 SYNLAB Details
9.8.2 SYNLAB Major Business
9.8.3 SYNLAB Antenatal Screening Product and Services
9.8.4 SYNLAB Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 SYNLAB Recent Developments/Updates
9.8.6 SYNLAB Competitive Strengths & Weaknesses
9.9 Veritas Genetics
9.9.1 Veritas Genetics Details
9.9.2 Veritas Genetics Major Business
9.9.3 Veritas Genetics Antenatal Screening Product and Services
9.9.4 Veritas Genetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Veritas Genetics Recent Developments/Updates
9.9.6 Veritas Genetics Competitive Strengths & Weaknesses
9.10 GGA
9.10.1 GGA Details
9.10.2 GGA Major Business
9.10.3 GGA Antenatal Screening Product and Services
9.10.4 GGA Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 GGA Recent Developments/Updates
9.10.6 GGA Competitive Strengths & Weaknesses
9.11 Cordlife
9.11.1 Cordlife Details
9.11.2 Cordlife Major Business
9.11.3 Cordlife Antenatal Screening Product and Services
9.11.4 Cordlife Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cordlife Recent Developments/Updates
9.11.6 Cordlife Competitive Strengths & Weaknesses
9.12 Rainbow Genomics
9.12.1 Rainbow Genomics Details
9.12.2 Rainbow Genomics Major Business
9.12.3 Rainbow Genomics Antenatal Screening Product and Services
9.12.4 Rainbow Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Rainbow Genomics Recent Developments/Updates
9.12.6 Rainbow Genomics Competitive Strengths & Weaknesses
9.13 BGI Genomics
9.13.1 BGI Genomics Details
9.13.2 BGI Genomics Major Business
9.13.3 BGI Genomics Antenatal Screening Product and Services
9.13.4 BGI Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BGI Genomics Recent Developments/Updates
9.13.6 BGI Genomics Competitive Strengths & Weaknesses
9.14 Berry Genomics
9.14.1 Berry Genomics Details
9.14.2 Berry Genomics Major Business
9.14.3 Berry Genomics Antenatal Screening Product and Services
9.14.4 Berry Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Berry Genomics Recent Developments/Updates
9.14.6 Berry Genomics Competitive Strengths & Weaknesses
9.15 Annaroad
9.15.1 Annaroad Details
9.15.2 Annaroad Major Business
9.15.3 Annaroad Antenatal Screening Product and Services
9.15.4 Annaroad Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Annaroad Recent Developments/Updates
9.15.6 Annaroad Competitive Strengths & Weaknesses
9.16 Jiajian Medical Testing
9.16.1 Jiajian Medical Testing Details
9.16.2 Jiajian Medical Testing Major Business
9.16.3 Jiajian Medical Testing Antenatal Screening Product and Services
9.16.4 Jiajian Medical Testing Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Jiajian Medical Testing Recent Developments/Updates
9.16.6 Jiajian Medical Testing Competitive Strengths & Weaknesses
9.17 Genesky
9.17.1 Genesky Details
9.17.2 Genesky Major Business
9.17.3 Genesky Antenatal Screening Product and Services
9.17.4 Genesky Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Genesky Recent Developments/Updates
9.17.6 Genesky Competitive Strengths & Weaknesses
9.18 Weihansi Biomedical Technology
9.18.1 Weihansi Biomedical Technology Details
9.18.2 Weihansi Biomedical Technology Major Business
9.18.3 Weihansi Biomedical Technology Antenatal Screening Product and Services
9.18.4 Weihansi Biomedical Technology Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Weihansi Biomedical Technology Recent Developments/Updates
9.18.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Antenatal Screening Industry Chain
10.2 Antenatal Screening Upstream Analysis
10.3 Antenatal Screening Midstream Analysis
10.4 Antenatal Screening Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Antenatal Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Antenatal Screening Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Antenatal Screening Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Antenatal Screening Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Antenatal Screening Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antenatal Screening Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Antenatal Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Antenatal Screening Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Antenatal Screening Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Antenatal Screening Players in 2025
Table 12. World Antenatal Screening Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Antenatal Screening Company Evaluation Quadrant
Table 14. Head Office of Key Antenatal Screening Players
Table 15. Antenatal Screening Market: Company Product Type Footprint
Table 16. Antenatal Screening Market: Company Product Application Footprint
Table 17. Antenatal Screening Mergers & Acquisitions Activity
Table 18. United States VS China Antenatal Screening Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Antenatal Screening Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Antenatal Screening Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antenatal Screening Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Antenatal Screening Revenue Market Share (2021-2026)
Table 23. China Based Antenatal Screening Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antenatal Screening Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Antenatal Screening Revenue Market Share (2021-2026)
Table 26. Rest of World Based Antenatal Screening Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Antenatal Screening Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Antenatal Screening Revenue Market Share (2021-2026)
Table 29. World Antenatal Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Antenatal Screening Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Antenatal Screening Market Size by Type (2027-2032) & (USD Million)
Table 32. World Antenatal Screening Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 33. World Antenatal Screening Market Size Value by Screening Timing (2021-2026) & (USD Million)
Table 34. World Antenatal Screening Market Size by Screening Timing (2027-2032) & (USD Million)
Table 35. World Antenatal Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Antenatal Screening Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Antenatal Screening Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Antenatal Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Antenatal Screening Market Size by Application (2021-2026) & (USD Million)
Table 40. World Antenatal Screening Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Antenatal Screening Product and Services
Table 44. Thermo Fisher Scientific Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Antenatal Screening Product and Services
Table 50. Revvity Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Antenatal Screening Product and Services
Table 56. Quest Diagnostics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Antenatal Screening Product and Services
Table 62. MedGenome Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Antenatal Screening Product and Services
Table 68. Mayo Clinic Laboratories Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. GeneDx Basic Information, Manufacturing Base and Competitors
Table 72. GeneDx Major Business
Table 73. GeneDx Antenatal Screening Product and Services
Table 74. GeneDx Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GeneDx Recent Developments/Updates
Table 76. GeneDx Competitive Strengths & Weaknesses
Table 77. PreventionGenetics Basic Information, Manufacturing Base and Competitors
Table 78. PreventionGenetics Major Business
Table 79. PreventionGenetics Antenatal Screening Product and Services
Table 80. PreventionGenetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. PreventionGenetics Recent Developments/Updates
Table 82. PreventionGenetics Competitive Strengths & Weaknesses
Table 83. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 84. SYNLAB Major Business
Table 85. SYNLAB Antenatal Screening Product and Services
Table 86. SYNLAB Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. SYNLAB Recent Developments/Updates
Table 88. SYNLAB Competitive Strengths & Weaknesses
Table 89. Veritas Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Veritas Genetics Major Business
Table 91. Veritas Genetics Antenatal Screening Product and Services
Table 92. Veritas Genetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Veritas Genetics Recent Developments/Updates
Table 94. Veritas Genetics Competitive Strengths & Weaknesses
Table 95. GGA Basic Information, Manufacturing Base and Competitors
Table 96. GGA Major Business
Table 97. GGA Antenatal Screening Product and Services
Table 98. GGA Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GGA Recent Developments/Updates
Table 100. GGA Competitive Strengths & Weaknesses
Table 101. Cordlife Basic Information, Manufacturing Base and Competitors
Table 102. Cordlife Major Business
Table 103. Cordlife Antenatal Screening Product and Services
Table 104. Cordlife Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cordlife Recent Developments/Updates
Table 106. Cordlife Competitive Strengths & Weaknesses
Table 107. Rainbow Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Rainbow Genomics Major Business
Table 109. Rainbow Genomics Antenatal Screening Product and Services
Table 110. Rainbow Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Rainbow Genomics Recent Developments/Updates
Table 112. Rainbow Genomics Competitive Strengths & Weaknesses
Table 113. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Major Business
Table 115. BGI Genomics Antenatal Screening Product and Services
Table 116. BGI Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Recent Developments/Updates
Table 118. BGI Genomics Competitive Strengths & Weaknesses
Table 119. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Berry Genomics Major Business
Table 121. Berry Genomics Antenatal Screening Product and Services
Table 122. Berry Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Berry Genomics Recent Developments/Updates
Table 124. Berry Genomics Competitive Strengths & Weaknesses
Table 125. Annaroad Basic Information, Manufacturing Base and Competitors
Table 126. Annaroad Major Business
Table 127. Annaroad Antenatal Screening Product and Services
Table 128. Annaroad Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Annaroad Recent Developments/Updates
Table 130. Annaroad Competitive Strengths & Weaknesses
Table 131. Jiajian Medical Testing Basic Information, Manufacturing Base and Competitors
Table 132. Jiajian Medical Testing Major Business
Table 133. Jiajian Medical Testing Antenatal Screening Product and Services
Table 134. Jiajian Medical Testing Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Jiajian Medical Testing Recent Developments/Updates
Table 136. Jiajian Medical Testing Competitive Strengths & Weaknesses
Table 137. Genesky Basic Information, Manufacturing Base and Competitors
Table 138. Genesky Major Business
Table 139. Genesky Antenatal Screening Product and Services
Table 140. Genesky Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Genesky Recent Developments/Updates
Table 142. Genesky Competitive Strengths & Weaknesses
Table 143. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 144. Weihansi Biomedical Technology Major Business
Table 145. Weihansi Biomedical Technology Antenatal Screening Product and Services
Table 146. Weihansi Biomedical Technology Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Weihansi Biomedical Technology Recent Developments/Updates
Table 148. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 149. Global Key Players of Antenatal Screening Upstream (Raw Materials)
Table 150. Global Antenatal Screening Typical Customers
Table 1. World Antenatal Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Antenatal Screening Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Antenatal Screening Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Antenatal Screening Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Antenatal Screening Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antenatal Screening Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Antenatal Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Antenatal Screening Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Antenatal Screening Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Antenatal Screening Players in 2025
Table 12. World Antenatal Screening Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Antenatal Screening Company Evaluation Quadrant
Table 14. Head Office of Key Antenatal Screening Players
Table 15. Antenatal Screening Market: Company Product Type Footprint
Table 16. Antenatal Screening Market: Company Product Application Footprint
Table 17. Antenatal Screening Mergers & Acquisitions Activity
Table 18. United States VS China Antenatal Screening Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Antenatal Screening Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Antenatal Screening Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antenatal Screening Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Antenatal Screening Revenue Market Share (2021-2026)
Table 23. China Based Antenatal Screening Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antenatal Screening Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Antenatal Screening Revenue Market Share (2021-2026)
Table 26. Rest of World Based Antenatal Screening Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Antenatal Screening Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Antenatal Screening Revenue Market Share (2021-2026)
Table 29. World Antenatal Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Antenatal Screening Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Antenatal Screening Market Size by Type (2027-2032) & (USD Million)
Table 32. World Antenatal Screening Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 33. World Antenatal Screening Market Size Value by Screening Timing (2021-2026) & (USD Million)
Table 34. World Antenatal Screening Market Size by Screening Timing (2027-2032) & (USD Million)
Table 35. World Antenatal Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Antenatal Screening Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Antenatal Screening Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Antenatal Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Antenatal Screening Market Size by Application (2021-2026) & (USD Million)
Table 40. World Antenatal Screening Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Antenatal Screening Product and Services
Table 44. Thermo Fisher Scientific Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Antenatal Screening Product and Services
Table 50. Revvity Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Antenatal Screening Product and Services
Table 56. Quest Diagnostics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Antenatal Screening Product and Services
Table 62. MedGenome Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Antenatal Screening Product and Services
Table 68. Mayo Clinic Laboratories Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. GeneDx Basic Information, Manufacturing Base and Competitors
Table 72. GeneDx Major Business
Table 73. GeneDx Antenatal Screening Product and Services
Table 74. GeneDx Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GeneDx Recent Developments/Updates
Table 76. GeneDx Competitive Strengths & Weaknesses
Table 77. PreventionGenetics Basic Information, Manufacturing Base and Competitors
Table 78. PreventionGenetics Major Business
Table 79. PreventionGenetics Antenatal Screening Product and Services
Table 80. PreventionGenetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. PreventionGenetics Recent Developments/Updates
Table 82. PreventionGenetics Competitive Strengths & Weaknesses
Table 83. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 84. SYNLAB Major Business
Table 85. SYNLAB Antenatal Screening Product and Services
Table 86. SYNLAB Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. SYNLAB Recent Developments/Updates
Table 88. SYNLAB Competitive Strengths & Weaknesses
Table 89. Veritas Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Veritas Genetics Major Business
Table 91. Veritas Genetics Antenatal Screening Product and Services
Table 92. Veritas Genetics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Veritas Genetics Recent Developments/Updates
Table 94. Veritas Genetics Competitive Strengths & Weaknesses
Table 95. GGA Basic Information, Manufacturing Base and Competitors
Table 96. GGA Major Business
Table 97. GGA Antenatal Screening Product and Services
Table 98. GGA Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GGA Recent Developments/Updates
Table 100. GGA Competitive Strengths & Weaknesses
Table 101. Cordlife Basic Information, Manufacturing Base and Competitors
Table 102. Cordlife Major Business
Table 103. Cordlife Antenatal Screening Product and Services
Table 104. Cordlife Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cordlife Recent Developments/Updates
Table 106. Cordlife Competitive Strengths & Weaknesses
Table 107. Rainbow Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Rainbow Genomics Major Business
Table 109. Rainbow Genomics Antenatal Screening Product and Services
Table 110. Rainbow Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Rainbow Genomics Recent Developments/Updates
Table 112. Rainbow Genomics Competitive Strengths & Weaknesses
Table 113. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 114. BGI Genomics Major Business
Table 115. BGI Genomics Antenatal Screening Product and Services
Table 116. BGI Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BGI Genomics Recent Developments/Updates
Table 118. BGI Genomics Competitive Strengths & Weaknesses
Table 119. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Berry Genomics Major Business
Table 121. Berry Genomics Antenatal Screening Product and Services
Table 122. Berry Genomics Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Berry Genomics Recent Developments/Updates
Table 124. Berry Genomics Competitive Strengths & Weaknesses
Table 125. Annaroad Basic Information, Manufacturing Base and Competitors
Table 126. Annaroad Major Business
Table 127. Annaroad Antenatal Screening Product and Services
Table 128. Annaroad Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Annaroad Recent Developments/Updates
Table 130. Annaroad Competitive Strengths & Weaknesses
Table 131. Jiajian Medical Testing Basic Information, Manufacturing Base and Competitors
Table 132. Jiajian Medical Testing Major Business
Table 133. Jiajian Medical Testing Antenatal Screening Product and Services
Table 134. Jiajian Medical Testing Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Jiajian Medical Testing Recent Developments/Updates
Table 136. Jiajian Medical Testing Competitive Strengths & Weaknesses
Table 137. Genesky Basic Information, Manufacturing Base and Competitors
Table 138. Genesky Major Business
Table 139. Genesky Antenatal Screening Product and Services
Table 140. Genesky Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Genesky Recent Developments/Updates
Table 142. Genesky Competitive Strengths & Weaknesses
Table 143. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 144. Weihansi Biomedical Technology Major Business
Table 145. Weihansi Biomedical Technology Antenatal Screening Product and Services
Table 146. Weihansi Biomedical Technology Antenatal Screening Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Weihansi Biomedical Technology Recent Developments/Updates
Table 148. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 149. Global Key Players of Antenatal Screening Upstream (Raw Materials)
Table 150. Global Antenatal Screening Typical Customers
LIST OF FIGURES
Figure 1. Antenatal Screening Picture
Figure 2. World Antenatal Screening Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Antenatal Screening Total Revenue (2021-2032) & (USD Million)
Figure 4. World Antenatal Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Antenatal Screening Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 13. Antenatal Screening Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 16. World Antenatal Screening Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 18. China Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 23. India Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Antenatal Screening by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antenatal Screening Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antenatal Screening Markets in 2025
Figure 27. United States VS China: Antenatal Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Antenatal Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Antenatal Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Antenatal Screening Market Size Market Share by Type in 2025
Figure 31. Serum Biomarker Screening
Figure 32. Ultrasonographic Imaging Screening
Figure 33. Others
Figure 34. World Antenatal Screening Market Size Market Share by Type (2021-2032)
Figure 35. World Antenatal Screening Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 36. World Antenatal Screening Market Size Market Share by Screening Timing in 2025
Figure 37. First-trimester Screening
Figure 38. Second-trimester Screening
Figure 39. Late-pregnancy Screening
Figure 40. World Antenatal Screening Market Size Market Share by Screening Timing (2021-2032)
Figure 41. World Antenatal Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 42. World Antenatal Screening Market Size Market Share by Service Model in 2025
Figure 43. Public Health Program
Figure 44. Consumer
Figure 45. Others
Figure 46. World Antenatal Screening Market Size Market Share by Service Model (2021-2032)
Figure 47. World Antenatal Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Antenatal Screening Market Size Market Share by Application in 2025
Figure 49. Public Hospitals
Figure 50. Private Hospitals
Figure 51. World Antenatal Screening Market Size Market Share by Application (2021-2032)
Figure 52. Antenatal Screening Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Antenatal Screening Picture
Figure 2. World Antenatal Screening Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Antenatal Screening Total Revenue (2021-2032) & (USD Million)
Figure 4. World Antenatal Screening Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Antenatal Screening Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Antenatal Screening Revenue (2021-2032) & (USD Million)
Figure 13. Antenatal Screening Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 16. World Antenatal Screening Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 18. China Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 23. India Antenatal Screening Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Antenatal Screening by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antenatal Screening Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antenatal Screening Markets in 2025
Figure 27. United States VS China: Antenatal Screening Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Antenatal Screening Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Antenatal Screening Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Antenatal Screening Market Size Market Share by Type in 2025
Figure 31. Serum Biomarker Screening
Figure 32. Ultrasonographic Imaging Screening
Figure 33. Others
Figure 34. World Antenatal Screening Market Size Market Share by Type (2021-2032)
Figure 35. World Antenatal Screening Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 36. World Antenatal Screening Market Size Market Share by Screening Timing in 2025
Figure 37. First-trimester Screening
Figure 38. Second-trimester Screening
Figure 39. Late-pregnancy Screening
Figure 40. World Antenatal Screening Market Size Market Share by Screening Timing (2021-2032)
Figure 41. World Antenatal Screening Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 42. World Antenatal Screening Market Size Market Share by Service Model in 2025
Figure 43. Public Health Program
Figure 44. Consumer
Figure 45. Others
Figure 46. World Antenatal Screening Market Size Market Share by Service Model (2021-2032)
Figure 47. World Antenatal Screening Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Antenatal Screening Market Size Market Share by Application in 2025
Figure 49. Public Hospitals
Figure 50. Private Hospitals
Figure 51. World Antenatal Screening Market Size Market Share by Application (2021-2032)
Figure 52. Antenatal Screening Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
